Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

Baker Capital Strategies

Free Registration

Register for access to news, tools, alerts and reports.

THEMA Basic included at launch.

Use at least 8 characters.

BCS
Home/The Filing Wire/AVADEL PHARMACEUTICALS PLC/ EFFECT

Notice of Effectiveness · EFFECT

AVADEL PHARMACEUTICALS PLC

Notice of Effectiveness

Filed Feb 13, 2026Accepted Feb 16, 2026, 7:15 PM ESTCIK 1012477Accession 9999999995-26-000566
View company →Permanent SEC source ↗
Share

Company context

Avadel Pharmaceuticals plc (Nasdaq: AVDL) is a biopharmaceutical company focused on transforming medicines to transform lives. Avadel’s approach includes applying innovative solutions to the development of medications that address the challenges patients face with current treatment options. Avadel’s commercial product, LUMRYZ™, was approved by the U.S. Food & Drug Administration as the first and only once-at-bedtime oxybate for extended-release oral suspension for the treatment of cataplexy or excessive daytime sleepiness in patients 7 years and older with narcolepsy. For more information, please visit Avadel’s website at www.avadel.com.

Historical securities (1)
AVDLNASDAQ · EQUITY · Historical · closed Feb 12, 2026

Recent company filings

  1. 15-12G filingFeb 23, 2026
  2. 4 filingFeb 18, 2026
  3. 3 filingFeb 18, 2026
  4. SCHEDULE 13G/A - filed by Two Seas Capital LP regarding AVADEL PHARMACEUTICALS PLCFeb 17, 2026
  5. SCHEDULE 13G/A - filed by JANUS HENDERSON GROUP PLC regarding AVADEL PHARMACEUTICALS PLCFeb 17, 2026

As-filed source

Primary evidence
As filedOpen full document ↗

Privacy choices

BCS measures page use with Google Analytics using regional consent settings. You can change your preference here. Charts and market data remain available.

Essential functions — always available. Security, navigation, registration and remembering these choices.

Audience analytics

Analytics cookies are off by default for visitors Google identifies in the EEA, UK or Switzerland until allowed. Limited measurement without analytics cookies may still occur under those regional defaults.

TradingView charts, quotes and the economic calendar load automatically as page content. TradingView receives network and browser information and may collect its own usage analytics. This choice controls BCS’s Google Analytics only.

Google advertising is not enabled. Direct sponsor links do not load advertising trackers on BCS.

Turning analytics off stops future Google Analytics activity here. It does not erase information already received by the provider. Read the privacy policy.